-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
UroGen Pharma Ltd. quarterly/annual Cost of Revenue history and growth rate from 2016 to 2023.
- UroGen Pharma Ltd. Cost of Revenue for the quarter ending June 30, 2024 was $2.23M, a 8.76% decline year-over-year.
- UroGen Pharma Ltd. Cost of Revenue for the twelve months ending June 30, 2024 was $8.61M, a 4.24% decline year-over-year.
- UroGen Pharma Ltd. annual Cost of Revenue for 2023 was $9.36M, a 22.3% increase from 2022.
- UroGen Pharma Ltd. annual Cost of Revenue for 2022 was $7.65M, a 48.4% increase from 2021.
- UroGen Pharma Ltd. annual Cost of Revenue for 2021 was $5.16M, a 411% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)